Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Signoretti

Showing results (251-260 of 257) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 257 results.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Cancer Discovery|March 24, 2026
Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor MicroenvironmentStephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, et al.
Nature|August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitorsShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
Pageof 26

Showing results (251-260 of 257) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 257 results.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F ActivityShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Cancer Cell|August 19, 2022
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant gliomaDiana D Shi, Milan R Savani, Michael M Levitt, et al.
Cancer Discovery|March 24, 2026
Same-Slide Spatial Multi-Omics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor MicroenvironmentStephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo, et al.
Nature|August 20, 2025
Targeting G1-S-checkpoint-compromised cancers with cyclin A/B RxL inhibitorsShilpa Singh, Catherine E Gleason, Min Fang, et al.
Nature|February 19, 2010
The landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H Mermel, Dale Porter, et al.
The New England Journal of Medicine|November 5, 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma, W Marston Linehan, Paul T Spellman, et al.
Pageof 26